PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance

U.S. Markets close in 3 hrs 4 mins

Pfizer Inc. (PFE)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
33.70+0.08 (+0.24%)
As of 12:55PM EST. Market open.
People also watch
MRKJNJJPMGEINTC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close33.62
Open33.57
Bid0.00 x
Ask0.00 x
Day's Range33.25 - 33.75
52 Week Range28.74 - 37.39
Volume12,388,162
Avg. Volume25,500,972
Market Cap204.51B
Beta1.02
PE Ratio (TTM)28.73
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.81%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals31 minutes ago

    Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company

    Philadelphia gene therapy company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children. The application for voretigene neparvovec— which is being submitted in parts to the Food and Drug Administration— is expected be done in early 2017, pending the finalization of the remaining release and stability testing, the company said. “We look forward to continued innovation, execution and growth in 2017, which may be a historic year for Spark Therapeutics and for patients as we potentially deliver what has been unimaginable before – the first gene therapy in the United States for a genetic disease,” said Jeffrey D. Marrazzo, the company’s co-founder and CEO.

  • Investopedia2 hours ago

    Momenta 4Q Net 60 Cents a Share

    Momenta’s 4Q earnings came in at a healthy 60 cents per share, or $41.5 million.

  • Market Realist4 hours ago

    Merck and Co.’s Segment-Wise Revenues for 4Q16

    The Animal Health segment’s contribution increased to 8.7% of total revenues for 4Q16, compared to 8.1% for 4Q15.